These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 3132176)

  • 1. Potency, selectivity and cell cycle dependence of catechols in human tumour cells in vitro.
    Kable EP; Parsons PG
    Biochem Pharmacol; 1988 May; 37(9):1711-5. PubMed ID: 3132176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
    Kable EP; Parsons PG
    Cancer Chemother Pharmacol; 1989; 23(1):1-7. PubMed ID: 2909284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.
    Yamada I; Seki S; Matsubara O; Ito S; Suzuki S; Kasuga T
    J Invest Dermatol; 1987 May; 88(5):538-40. PubMed ID: 3572026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of dopa toxicity in human tumour cells.
    Parsons PG
    Biochem Pharmacol; 1985 May; 34(10):1801-7. PubMed ID: 3924049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo depigmentation by hydroxybenzene derivatives.
    Menter JM; Etemadi AA; Chapman W; Hollins TD; Willis I
    Melanoma Res; 1993 Dec; 3(6):443-9. PubMed ID: 8161883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of the substituted catechols dihydroxyphenylalanine methyl ester and trihydroxyphenylalanine by lactoperoxidase and its compounds.
    Metodiewa D; Reszka K; Dunford HB
    Arch Biochem Biophys; 1989 Nov; 274(2):601-8. PubMed ID: 2552928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of antitumoral activity of catechols in culture.
    Picardo M; Passi S; Nazzaro-Porro M; Breathnach A; Zompetta C; Faggioni A; Riley P
    Biochem Pharmacol; 1987 Feb; 36(4):417-25. PubMed ID: 3103624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.
    Kern DH; Shoemaker RH; Hildebrand-Zanki SU; Driscoll JS
    Cancer Res; 1988 Sep; 48(18):5178-82. PubMed ID: 3136917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.
    Parsons PG; Morrison LE
    Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity of (chloro-)catechols and (chloro-)catechol-copper combinations in Escherichia coli corresponds to their membrane toxicity in vitro.
    Schweigert N; Hunziker RW; Escher BI; Eggen RI
    Environ Toxicol Chem; 2001 Feb; 20(2):239-47. PubMed ID: 11351422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and selective toxicity of tetra(hydroxyphenyl)- and tetrakis(dihydroxyphenyl)porphyrins in human melanoma cells, with and without exposure to red light.
    James DA; Arnold DP; Parsons PG
    Photochem Photobiol; 1994 Apr; 59(4):441-7. PubMed ID: 8022886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of toxicity of 5-S-cysteinyldopa to tumour cells. Hydrogen peroxide as a mediator of cytotoxicity.
    Ito S; Inoue S; Fujita K
    Biochem Pharmacol; 1983 Jul; 32(13):2079-81. PubMed ID: 6409113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
    Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
    Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human melanoma cells sensitive to deoxyadenosine and deoxyinosine.
    Parsons PG; Hayward IP
    Biochem Pharmacol; 1986 Feb; 35(4):655-60. PubMed ID: 3004507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure toxicity relationships for catechols in isolated rat hepatocytes.
    Moridani MY; Siraki A; Chevaldina T; Scobie H; O'Brien PJ
    Chem Biol Interact; 2004 Apr; 147(3):297-307. PubMed ID: 15135085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cytotoxicity of catechols and a naphthalenediol in PC12-AC cells: the connection between extracellular autoxidation and molecular electronic structure.
    Chichirau A; Flueraru M; Chepelev LL; Wright JS; Willmore WG; Durst T; Hussain HH; Charron M
    Free Radic Biol Med; 2005 Feb; 38(3):344-55. PubMed ID: 15629863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide as an inducer of elevated tyrosinase level in melanoma cells.
    Karg E; Odh G; Wittbjer A; Rosengren E; Rorsman H
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):209S-213S. PubMed ID: 8433009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.
    Zafar KS; Siegel D; Ross D
    Mol Pharmacol; 2006 Sep; 70(3):1079-86. PubMed ID: 16790533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.